4:33 PM
 | 
Oct 06, 2017
 |  BC Extra  |  Company News

Management tracks: Impel, InGeneron

Drug delivery company Impel NeuroPharma Inc. (Seattle, Wash.) named Jon Congleton president and CEO. He was president and CEO at Nivalis Therapeutics Inc., which merged with Alpine Immune Sciences Inc. (NASDAQ:ALPN).

Regenerative medicine company InGeneron Inc. (Houston, Texas) named Angelo Moesslang CEO. He was CFO of the Fresenius Medical Care North America Holdings Inc. unit of Fresenius SE & Co. KGaA (Xetra:FRE;...

Read the full 314 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >